Ikram UZ, Mackenbach JP, Harding S, Rey G, Bhopal RS, Regidor E, et al. All-cause and cause-specific mortality of different migrant populations in Europe. Eur J Epidemiol. 2015 Sep 11;
Ikram UZ, Malmusi D, Juel K, Rey G, Kunst AE. Association between Integration Policies and Immigrants’ Mortality: An Explorative Study across Three European Countries. PLoS ONE. 2015;10(6):e0129916.
Moreno-Betancur M, Rey G, Latouche A. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure. Biometrics. 2015 Jun;71(2):498–507.
Lamarche-Vadel A, Ngantcha M, Le Pogam M-A, Ghosn W, Grenier C, Meyer L, et al. Hospital comparisons based on mortality: revisiting the choice of postadmission timeframe and evaluating the contribution of cause-of-death data, France, 2009. Med Care. 2015 Aug;53(8):736–42.
Laanani M, Ghosn W, Jougla E, Rey G. Impact of unemployment variations on suicide mortality in Western European countries (2000-2010): authors’ reply. J Epidemiol Community Health. 2015 Aug;69(8):819–20.
Laanani M, Ghosn W, Jougla E, Rey G. Impact of unemployment variations on suicide mortality in Western European countries (2000-2010). J Epidemiol Community Health. 2015 Feb;69(2):103–9.
Antero-Jacquemin J, Rey G, Marc A, Dor F, Haïda A, Marck A, et al. Mortality in female and male French Olympians: a 1948-2013 cohort study. Am J Sports Med. 2015 Jun;43(6):1505–12.
Moreno-Betancur M, Latouche A, Menvielle G, Kunst AE, Rey G. Relative index of inequality and slope index of inequality: a structured regression framework for estimation. Epidemiology. 2015 Jul;26(4):518–27.
Karimi M, Geoffroy-Perez B, Fouquet A, Latouche A, Rey G. Socioprofessional trajectories and mortality in France, 1976-2002: a longitudinal follow-up of administrative data. J Epidemiol Community Health. 2015 Apr;69(4):339–46.
Rondet C, Parizot I, Cadwallader JS, Lebas J, Chauvin P. Why underserved patients do not consult their general practitioner for depression: results of a qualitative and a quantitative survey at a free outpatient clinic in Paris, France. BMC Family Practice [Internet]. 2015 [cited 2018 Jan 3];16(1). Available from: http://bmcfampract.biomedcentral.com/articles/10.1186/s12875-015-0273-2
Rey G, Jougla E. Are alcohol-attributable mortality estimates reliable? Eur J Public Health. 2014 Feb;24(1):3–4.
Viallon V, Banerjee O, Jougla E, Rey G, Coste J. Empirical comparison study of approximate methods for structure selection in binary graphical models. Biom J. 2014 Mar;56(2):307–31.
Saucedo M, Bouvier-Colle M-H, Chantry AA, Lamarche-Vadel A, Rey G, Deneux-Tharaux C. Pitfalls of national routine death statistics for maternal mortality study. Paediatr Perinat Epidemiol. 2014 Nov;28(6):479–88.
Lefeuvre D, Pavillon G, Aouba A, Lamarche-Vadel A, Fouillet A, Jougla E, et al. Quality comparison of electronic versus paper death certificates in France, 2010. Popul Health Metr. 2014;12(1):3.
Romon I, Rey G, Mandereau-Bruno L, Weill A, Jougla E, Eschwège E, et al. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort. Diabet Med. 2014 Aug;31(8):946–53.
Hoffmann R, Plug I, Khoshaba B, McKee M, Mackenbach JP, AMIEHS working group. Amenable mortality revisited: the AMIEHS study. Gac Sanit. 2013 Jun;27(3):199–206.
Menvielle G, Rey G, Jougla E, Luce D. Diverging trends in educational inequalities in cancer mortality between men and women in the 2000s in France. BMC Public Health. 2013 Sep 10;13(1):823.
Hoffmann R, Plug I, McKee M, Khoshaba B, Westerling R, Looman C, et al. Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005. Int J Public Health. 2013 Aug 29;
Hoffmann R, Plug I, McKee M, Khoshaba B, Westerling R, Looman C, et al. Innovations in medical care and mortality trends from four circulatory diseases between 1970 and 2005. Eur J Public Health. 2013 Oct;23(5):852–7.
Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, Celermajer DS, et al. Mortality of French participants in the Tour de France (1947-2012). Eur Heart J. 2013 Oct;34(40):3145–50.
Rafnsson SB, Bhopal RS, Agyemang C, Fagot-Campagna A, Harding S, Hammar N, et al. Sizable variations in circulatory disease mortality by region and country of birth in six European countries. Eur J Public Health. 2013 Aug;23(4):594–605.
Ghosn W, Kassie D, Jougla E, Rican S, Rey G. Spatial interactions between urban areas and cause-specific mortality differentials in France. Health Place. 2013 Nov;24:234–41.
Ghosn W, Kassié D, Jougla E, Salem G, Rey G, Rican S. Trends in geographic mortality inequalities and their association with population changes in France, 1975-2006. Eur J Public Health. 2013 Oct;23(5):834–40.
Mackenbach JP, Hoffmann R, Khoshaba B, Plug I, Rey G, Westerling R, et al. Using “amenable mortality” as indicator of healthcare effectiveness in international comparisons: results of a validation study. J Epidemiol Community Health. 2013 Feb;67(2):139–46.
Fouillet A, Rey G, Jougla E, Frayssinet P, Bessemoulin P, Hémon D. A predictive model relating daily fluctuations in summer temperatures and mortality rates. BMC Public Health. 2007;7:114.
Lavallée PC, Labreuche J, Spieler JF, Jougla E, Amarenco P. Stroke and vascular mortality trends in France: 1979-200Neuroepidemiology. 2007;29(1–2):78–82.
Rey G, Jougla E, Fouillet A, Pavillon G, Bessemoulin P, Frayssinet P, et al. The impact of major heat waves on all-cause and cause-specific mortality in France from 1971 to 2003. Int Arch Occup Environ Health. 2007 Jul;80(7):615–26.
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Peng J, Ménégoz F, Lesec’h JM, Remontet L, Grosclaude P, Buémi A, et al. [Larynx cancer in France: descriptive epidemiology and incidence estimation]. Bull Cancer. 2004 Apr;91(4):363–8.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.